Skip to content

Computer-assisted Cognitive-Behavior Therapy for Depression in Primary Care

Dissemination of Computer-assisted Cognitive-behavior Therapy for Depression in Primary Care

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02700009
Enrollment
176
Registered
2016-03-07
Start date
2016-05-31
Completion date
2020-12-31
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Brief summary

Computer-assisted cognitive-behavior therapy, a treatment that has been shown to be effective in previous studies in psychiatric settings, will be disseminated into primary care - a health care setting where there are significant problems in receiving adequate treatment for depression. Computer-assisted cognitive-behavior therapy will feature a low-cost method of delivering therapy designed to be replicated and sustained in other primary care settings. Feasibility and effectiveness will be tested by randomly assigning 320 primary care patients with depression to receive either computer-assisted cognitive-behavior therapy or treatment as usual.

Detailed description

Computer-assisted cognitive-behavior therapy (CCBT) for depression in primary care will be evaluated in a trial with 320 patients randomly assigned to CCBT or treatment as usual (TAU). The study will disseminate a therapy method found to be effective in psychiatric settings into primary care - a setting where there have been significant problems in delivery of adequate, evidence-based treatment for depression. The study will include a high percentage of disadvantaged patients - a population that has been largely ignored in previous research in CCBT. There have been no previous studies of CCBT for depression in primary care that have enrolled large numbers of disadvantaged patients. The form of CCBT used in this study is designed to increase access to effective therapy, provide a cost-effective method, and be a sustainable model for wide-spread use in primary care. In order to deliver therapy in a practical manner that can be replicated in other primary care practices, patients with significant symptoms of depression will receive treatment with an empirically supported computer program that builds cognitive-behavior therapy skills. Support for CCBT will be provided by telephone and/or e-mail contact with a care coordinator instead of the face-to-face treatment with a cognitive-behavior therapist that has been a part of CCBT delivery in mental health settings. Novel features of this treatment program include: 1) fully detailed and replicable method for integrating clinician support with CCBT in primary care; 2) delivery of CCBT to a population with high percentage of disadvantaged patients; 3) integration of CCBT into the primary care delivery model; 4) highly interactive, multimedia computer program with adaptations for persons who may have lower levels of education or computer experience; 5) advanced cost-benefit analysis including data on actual health care utilization and costs; 6) exploration of moderators and predictors of treatment outcome. Outcome will be assessed by measuring CCBT completion rate, comprehension of CBT concepts, and satisfaction with treatment; in addition to ratings of depressive symptoms, negative thoughts, and quality of life. The cost-effectiveness analysis and exploration of possible predictors of outcome should help clinicians, health care organizations, and others plan further dissemination of CCBT in primary care.

Interventions

BEHAVIORALComputer-assisted CBT (CCBT)

Computer-assisted psychotherapy for depression using a computer program plus clinician support

OTHERTreatment as Usual (TAU)

Ordinary treatment for depression in primary care setting

Sponsors

University of Denver
CollaboratorOTHER
University of York
CollaboratorOTHER
University of Louisville
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patient Health Questionnaire score of 10 or above 2. Age 18 or above

Exclusion criteria

1. Refusal to provide informed consent 2. Inability to read English text on computer screen 3. Significant suicidal thoughts, intent, plan, or behavior reported on Columbia Suicide Severity Rating Scale 4. Severe or poorly controlled medical disorders that would interfere with participation in CCBT (e.g., liver failure, terminal cancer) 5. Dementia or other organic brain disorders that would prevent participation in CCBT 6. Diagnosis of any psychotic disorder or bipolar disorder.

Design outcomes

Primary

MeasureTime frameDescription
Patient Health Questionnaire - 9Change from baseline after 12 weeks of treatment and 3 and 6 months after the 12-week treatment period endsSelf-report scale for depression

Secondary

MeasureTime frameDescription
Quality of Life Enjoyment and Satisfaction QuestionnaireChange from baseline after 12 weeks of treatment and 3 and 6 months after the 12-week treatment period endsSelf-report measure of quality of life
Client Service Receipt InventoryChange from baseline after 12 weeks of treatment and 3 and 6 months after 12-week treatment endsRecord of medical and related services
Automatic Thoughts QuestionnaireChange from baseline after 12 weeks of treatment and 3 and 6 months after the 12-week treatment period endsSelf-report measure of negative cognitions
Patient Attitudes and Expectations ScaleChange from baseline after 12 weeks of treatment and 3 and 6 months after the 12-week treatment periods endsAssessment of patient attitudes toward treatment
Generalized Anxiety Disorder - 7Change from baseline after 12 weeks of treatment and 3 and 6 months after the 12-week treatment period endsSelf-report measure of anxiety
Quality of Well Being ScaleChange from baseline after 12 weeks of treatment and 3 and 6 months after the 12-week treatment periods endsSelf-report measure of well-being

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026